1-2 of 2
Torben Falck Ørntoft
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy

Karina Dalsgaard Sørensen, Peter Johannes Wild, Ashkan Mortezavi, Katja Adolf, Niels Tørring, Sara Heebøll, Benedicte Parm Ulhøi, Peter Ottosen, Tullio Sulser, Thomas Hermanns, Holger Moch, Michael Borre, Torben Falck Ørntoft, Lars Dyrskjøt
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1400–1410.
https://doi.org/10.1158/1078-0432.CCR-08-2268
Published: 19 February 2009
View article titled, Genetic and Epigenetic <em>SLC18A2</em> Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
Open the PDF for Genetic and Epigenetic <em>SLC18A2</em> Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Role of Activating Fibroblast Growth Factor Receptor 3 Mutations in the Development of Bladder Tumors

Karsten Zieger, Lars Dyrskjøt, Carsten Wiuf, Jens L. Jensen, Claus L. Andersen, Klaus Møller-Ernst Jensen, Torben Falck Ørntoft
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7709–7719.
https://doi.org/10.1158/1078-0432.CCR-05-1130
Published: 08 November 2005
View article titled, Role of Activating <em>Fibroblast Growth Factor Receptor 3</em> Mutations in the Development of Bladder Tumors
Open the PDF for Role of Activating <em>Fibroblast Growth Factor Receptor 3</em> Mutations in the Development of Bladder Tumors in another window
Includes: Supplementary data